Deflazacort
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Deflazacort and local guidelines before prescribing.
Glucocorticoid
Mechanism
Glucocorticoid.
Uses
Duchenne muscular dystrophy.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Weight gain, cataract, growth retardation, adrenal suppression.
Interactions
CYP3A4 inducers reduce effect.
Contraindications and cautions
Systemic infection
Monitoring
Growth, bone
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Caution in hepatic impairment
Overdose and reversal
Supportive
Special advice
Steroid card and sick-day rules.
More from the textbook: uses, cautions and other points
- Management - corticosteroids (prednisolone, deflazacort or vamorolone) to slow decline; physiotherapy, night splints; cardiac monitoring (ACE inhibitors); non-invasive ventilation ; scoliosis surgery; bone health; steroid emergency planning; genetic counselling (carrier testing for mother and sisters). Some genetic therapies (e.g. …
Paediatrics: Neurology, bones and joints in children - Treatment - corticosteroids (prednisolone, deflazacort, vamorolone) prolong walking; ACE inhibitors and cardiac monitoring; non-invasive ventilation; spinal surgery; exon-skipping drugs and gene therapies (availability varies - specialist).
Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders - Corticosteroids (deflazacort, prednisolone, or vamorolone).
Neurology: Neuromuscular disease - Prednisolone / deflazacort / vamorolone | Duchenne muscular dystrophy - slows decline.
Paediatrics: Neurology, bones and joints in children
Where it is discussed in the book
- Neurology: Neuromuscular disease (1 mention)
- Paediatrics: Neurology, bones and joints in children (2 mentions)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (1 mention)
- Integrated paediatrics chapter (2 mentions)